Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Diabetes mellitusLung cancerLymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CDON | Q4KMG0 | Cell adhesion molecule-related/down-regulated by oncogenes | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.25 | |||
| CEAM1 | P13688 | Cell adhesion molecule CEACAM1 (Biliary glycoprotein 1) (BGP-1) (Carcinoembryonic antigen-related cell adhesion molecule 1) (CEA cell adhesion molecule 1) (CD antigen CD66a) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CK024 | Q96F05 | Uncharacterized protein C11orf24 (Protein DM4E3) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 | |||
| CLCN2 | P51788 | Chloride channel protein 2 (ClC-2) | Disease related genesFDA approved drug targetsHuman disease related genes | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CLDN1 | Q9NY35 | Claudin domain-containing protein 1 (Claudin-25) (Membrane protein GENX-3745) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 4 | Fusion and delivery mediation | 1 | 0.25 | |||
| CLTR1 | Q9Y271 | Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaMigraine | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||
| CTL2 | Q8IWA5 | Choline transporter-like protein 2 (Solute carrier family 44 member 2) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CTL5 | Q8NCS7 | Choline transporter-like protein 5 (Solute carrier family 44 member 5) | Metabolic proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediationMetabolism mediation | 1 | 0.25 | |||
| CTNS | O60931 | Cystinosin | 7 | Amino acid absorption/transport disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CTR1 | P30825 | High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) | Metabolic proteinsPredicted membrane proteinsTransporters | 14 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CXCR5 | P32302 | C-X-C chemokine receptor type 5 (CXC-R5) (CXCR-5) (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15) (MDR-15) (CD antigen CD185) | CD markersG-protein coupled receptorsPredicted membrane proteins | 7 | Lupus erythematosusSolid tumour/cancerThrombocytopenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| DNER | Q8NFT8 | Delta and Notch-like epidermal growth factor-related receptor | Cancer-related genesPredicted membrane proteins | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| DPA1 | P20036 | HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1) | Human disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| DPB1 | P04440 | HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1) | Human disease related genesPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| DQA1 | P01909 | HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1) | Human disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| DQA2 | P01906 | HLA class II histocompatibility antigen, DQ alpha 2 chain (DX alpha chain) (HLA class II histocompatibility antigen, DQ(6) alpha chain) (HLA-DQA1) (MHC class II DQA2) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| DRB1 | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1) (HLA-DRB1) | Disease related genesHuman disease related genesPlasma proteins | 1 | Multiple sclerosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| DRB5 | Q30154 | HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5) | Human disease related genesPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| EAA1 | P43003 | Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3) | Cancer-related genesDisease related genesHuman disease related genes | 8 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.25 | |||
| ECE1 | P42892 | Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) | Disease related genesEnzymesHuman disease related genes | 1 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.25 | |||
| EFNB2 | P52799 | Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L) | Cancer-related genesPlasma proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| EMB | Q6PCB8 | Embigin | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||||
| ENPP4 | Q9Y6X5 | Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4) | EnzymesPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| F174B | Q3ZCQ3 | Membrane protein FAM174B | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 |